Cytotoxic purine nucleoside analogues bind to A ₁, A _2A, and A ₃ adenosine receptors

Keyphrases

• Clofarabine 100%
• A3 Adenosine Receptor 100%
• Purine nucleoside Analogues 100%
• Cladribine 80%
• Fludarabine 80%
• Adenosine 60%
• Adenosine Receptor Subtypes 60%
• Nucleoside Analogues 40%
• Neurotoxicity 20%
• Chinese Hamster Ovary Cells 20%
• Anticancer Agents 20%
• Gemcitabine 20%
• Cancer Treatment 20%
• Cytarabine 20%
• Binding Affinity 20%
• IC50 20%
• Adenosine Receptors 20%
• Receptor Subtypes 20%
• Adenylyl Cyclase Activity 20%
• Purine nucleosides 20%
• Toxic Effects 20%
• Radioligand Binding Studies 20%
• Cardiac Toxicity 20%
• Adenosine Analogue 20%
• 1 Receptor 20%
• Pyrimidine nucleoside Analogs 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Receptor 100%
• Purine Nucleoside Derivative 100%
• Adenosine Receptor 100%
• Clofarabine 83%
• Cladribine 66%
• Receptor Subtype 66%
• Fludarabine 66%
• Adenosine 50%
• Nucleoside Analog 50%
• Pyrimidine Nucleoside 16%
• Malignant Neoplasm 16%
• Anticarcinogen 16%
• Adenylate Cyclase 16%
• Radioligand 16%
• Purine Nucleoside 16%
• Adenosine Derivative 16%
• IC50 16%
• Gemcitabine 16%
• Cytarabine 16%
• Chinese Hamster 16%